Quantcast

Latest National Cancer Institute Stories

2014-07-28 23:01:12

Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in the U.S. die each year from metastatic breast and prostate cancers – an aggressive form of the disease that occurs when the cancer has spread to other parts of the body, such as the lungs, liver, bones, or brain. Now researchers at Drexel University College of Medicine have developed a compound directed at a target they identified that...

2014-07-08 08:29:42

CALGARY, July 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN(®) versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045). The principal investigator is Tanios Bekaii-Saab, MD, associate professor and gastrointestinal oncology section...

2014-07-07 08:25:14

NEW YORK, July 7, 2014 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD) today announced that its Board of Directors has appointed Kristiina Vuori, M.D., Ph.D., President and Interim CEO of Sanford-Burnham Medical Research Institute, to the Company's Board. The Institute is a non-profit research organization that is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow, with major research programs in cancer,...

2014-07-01 16:30:23

Report Stems From National Grassroots Advocacy To Require New Strategic Plans Of Action To Address Deadliest Cancers WASHINGTON, July 1, 2014 /PRNewswire-USNewswire/ -- Today the National Cancer Institute (NCI), led by Harold Varmus, MD, presented to Congress a scientific framework that lays out important steps needed to make advances in small cell lung cancer, one of the most lethal forms of the disease. The report, entitled "Scientific Framework for Small Cell Lung Cancer (SCLC)" was...

2014-06-17 08:28:03

Nearly 500 Pancreatic Cancer Advocates Head to Capitol Hill Today MANHATTAN BEACH, Calif., June 17, 2014 /PRNewswire/ -- Nearly 500 people from across the country are on Capitol Hill today for the eighth annual Pancreatic Cancer Advocacy Day urging Congress to stomp on pancreatic cancer by stepping up federal research funding. Advocates from the Pancreatic Cancer Action Network will call on Congress to provide $5.26 billion for the National Cancer Institute (NCI) for FY15 and...

2014-06-16 08:29:32

The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16, 2014 /PRNewswire/ -- A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen,...

2014-06-11 16:27:29

St. Jude Comprehensive Cancer Center receives "exceptional" score from National Cancer Institute--highest rating awarded to cancer centers MEMPHIS, Tenn., June 11, 2014 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital's designation as a Comprehensive Cancer Center has been renewed by the National Cancer Institute (NCI), earning the highest possible score of "exceptional." St. Jude remains the first and only NCI-designated Comprehensive Cancer Center that is devoted...

2014-06-04 15:29:19

Albert Einstein College of Medicine The study was led by researchers at the National Cancer Institute (NCI)─designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein Center for Cancer Care and was published online today in the Journal of the National Cancer Institute (JNCI). "Tests assessing metastatic risk can help doctors identify which patients should receive aggressive therapy and which patients should be spared,"...

2014-05-30 08:25:14

Retrospective Analysis Demonstrates Survival Benefits for Patients with Stable and Progressive Disease after HD IL-2 in the Modern Era Suggesting Appropriate Drug Sequencing May Improve Outcomes CHICAGO, May 30, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that analysis of data from the PROCLAIM(SM) national patient registry retrospective cohort shows improved overall survival in metastatic RCC patients treated with high-dose Proleukin(®) (aldesleukin) in the...

herpes virus attack a brain tumor cell
2014-05-18 03:00:47

Harvard Stem Cell Institute (HSCI) Harvard Stem Cell Institute (HSCI) scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses. The investigators report that trapping virus-loaded stem cells in a gel and applying them to tumors significantly improved survival in mice with glioblastoma multiforme, the most common brain tumor in human adults and also the most difficult to treat. The work, led by Khalid...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related